National Healthcare CorporationAMEX: NHC

NHC Reports 2025 Year End Earnings

MURFREESBORO, Tenn., February 26, 2026--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2025 totaled $1,517,781,000 compared to $1,307,382,000 for the year ended December 31, 2024, an increase of 16.1%. The increase in net operating revenues for the 2025 year compared to the 2024 year was due to an 8.4% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Manor ("White Oak"). The White Oak operations consist of 22 healthcare operations, which includes 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy.

For the year ended December 31, 2025, the reported GAAP net income attributable to NHC was $120,015,000 compared to $101,927,000 for the 2024 year. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the year ended December 31, 2025 was $104,067,000 compared to $76,862,000 for the 2024 year (*), an increase of 35.4%. GAAP diluted earnings per share were $7.67 and $6.53 for the years ended December 31, 2024 and 2023, respectively. Adjusted diluted earnings per share were $6.65 and $4.93 for the years ended December 31, 2025 and 2024, respectively (*).

For the quarter ended December 31, 2025, the reported GAAP net income attributable to NHC was $24,849,000 compared to $6,081,000 for the same period in 2024. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended December 31, 2025 was $28,774,000 compared to $25,954,000 for the same period in 2024, an increase of 10.9% (*). The GAAP diluted earnings per share were $1.58 and $0.39 for the quarters ended December 31, 2025 and 2024, respectively. Adjusted diluted earnings per share were $1.83 and $1.66 for the quarters ended December 31, 2025 and 2024, respectively (*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

As of February 1, 2026, NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,329 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

Three Months Ended

Years Ended

December 31

December 31

2025

2024

2025

2024

Revenues:

Net patient revenues

$

373,686

$

357,344

$

1,469,631

$

1,251,759

Other revenues

12,827

12,006

48,150

46,178

Government stimulus income

-

-

-

9,445

Net operating revenues and grant income

386,513

369,350

1,517,781

1,307,382

Costs and expenses:

Salaries, wages and benefits

233,240

234,321

921,080

810,930

Other operating

96,198

83,298

377,202

321,390

Facility rent

12,189

11,378

46,227

43,182

Depreciation and amortization

11,769

11,442

44,920

41,985

Total costs and expenses

353,396

340,439

1,389,429

1,217,487

Income from operations

33,117

28,911

128,352

89,895

Non-operating income

4,236

4,825

18,107

19,690

Interest expense

(816

)

(2,347

)

(6,371

)

(4,135

)

Unrealized gains on marketable equity securities

(4,404

)

(25,332

)

22,344

30,958

Income before income taxes

32,133

6,057

162,432

136,408

Income tax provision

(6,939

)

(28

)

(39,826

)

(34,322

)

Net income

25,194

6,029

122,606

102,086

Net income attributable to noncontrolling interest

(345

)

52

(2,591

)

(159

)

Net income attributable to National HealthCare Corporation

$

24,849

$

6,081

$

120,015

$

101,927

Net income per common share

Basic

$

1.60

$

0.39

$

7.76

$

6.62

Diluted

$

1.58

$

0.39

$

7.67

$

6.53

Weighted average common shares outstanding

Basic

15,502,990

15,420,658

15,472,185

15,393,782

Diluted

15,744,478

15,665,025

15,646,338

15,598,528

Dividends declared per common share

$

0.64

$

0.61

$

2.53

$

2.42

Balance Sheet Data

December 31

December 31

(in thousands)

2025

2024

Cash, cash equivalents and marketable securities

$

255,801

$

216,185

Restricted cash, cash equivalents and marketable securities

159,848

163,795

Current assets

461,820

424,408

Property and equipment, net

673,797

684,289

Total assets

1,526,419

1,524,429

Current liabilities, excluding current long-term debt

246,132

227,297

Current and long-term debt

40,000

137,000

NHC stockholders' equity

1,068,772

980,161

Selected Operating Statistics

Three Months Ended

Years Ended

December 31

December 31

2025

2024

2025

2024

Skilled Nursing Per Diems:

Medicare

$

626.99

$

607.67

$

616.75

$

586.76

Managed Care

539.69

490.41

486.56

468.23

Medicaid

289.05

279.02

285.46

275.78

Private Pay and Other

340.12

321.12

338.28

316.80

Average Skilled Nursing Per Diem

$

369.21

$

350.72

$

360.40

$

346.46

(1)

Skilled Nursing Patient Days:

Medicare

83,750

84,809

336,120

320,524

Managed Care

82,425

76,996

330,424

276,019

Medicaid

370,805

374,755

1,473,029

1,281,020

Private Pay and Other

203,408

191,926

788,843

677,449

Total Skilled Nursing Patient Days

740,388

728,486

2,928,416

2,555,012

(1)

(1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the year ended December 31, 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $275.64 and 20,267 patient days.

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

Three Months Ended

Years Ended

December 31

December 31

2025

2024

2025

2024

Net income attributable to National Healthcare Corporation

$

24,849

$

6,081

$

120,015

$

101,927

Non-GAAP adjustments

Unrealized gains on marketable equity securities

4,404

25,332

(22,344

)

(30,958

)

Operating results for newly-opened operations not at full capacity

-

(10

)

-

130

Gain on sale of unconsolidated company

-

-

-

(1,024

)

Gain on sale of property and equipment

-

-

(3,606

)

-

Stock-based compensation expense

900

1,098

4,399

4,160

Acquisition-related expenses

-

435

-

3,266

Employee retention credit

-

-

-

(9,445

)

Income tax provision on non-GAAP adjustments

(1,379

)

(6,982

)

5,603

8,806

Non-GAAP Net income

$

28,774

$

25,954

$

104,067

$

76,862

GAAP diluted earnings per share

$

1.58

$

0.39

$

7.67

$

6.53

Non-GAAP adjustments

Unrealized gains on marketable equity securities

0.28

1.62

(1.43

)

(1.98

)

Operating results for newly-opened operations not at full capacity

-

-

-

0.01

Gain on sale of unconsolidated company

-

-

-

(0.07

)

Gain on sale of property and equipment

-

-

(0.23

)

-

Stock-based compensation expense

0.06

0.07

0.28

0.28

Acquisition-related expenses

-

0.03

-

0.21

Employee retention credit

-

-

-

(0.61

)

Income tax provision on non-GAAP adjustments

(0.09

)

(0.45

)

0.36

0.56

Non-GAAP diluted earnings per share

$

1.83

$

1.66

$

6.65

$

4.93

View source version on businesswire.com: https://www.businesswire.com/news/home/20260226128991/en/

Contacts

Brian F. Kidd, SVP/CFO
Phone: (615) 890-2020

Earlier from National Healthcare

All National Healthcare news releases